|
Volumn 34, Issue 4, 2009, Pages 380-381
|
Artesunate plus sulfamethoxypyrazine/pyrimethamine for the treatment of cutaneous leishmaniasis: a double-blind, placebo-controlled clinical trial
|
Author keywords
Artesunate; Leishmaniasis; Sudan; Sulfamethoxypyrazine pyrimethamine
|
Indexed keywords
ARTESUNATE;
CO ARINATE;
METAKELFIN;
PENTOSAM;
PLACEBO;
STIBOGLUCONATE SODIUM;
UNCLASSIFIED DRUG;
ADULT;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG TREATMENT FAILURE;
HUMAN;
LETTER;
PILOT STUDY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REPEATED DRUG DOSE;
SKIN LEISHMANIASIS;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
ANTI-INFECTIVE AGENTS;
ANTIPROTOZOAL AGENTS;
ARTEMISININS;
CHILD;
DOUBLE-BLIND METHOD;
DRUG THERAPY, COMBINATION;
HUMANS;
LEISHMANIASIS, CUTANEOUS;
MIDDLE AGED;
PYRIMETHAMINE;
SULFALENE;
TREATMENT OUTCOME;
|
EID: 67849108318
PISSN: 09248579
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ijantimicag.2009.03.013 Document Type: Letter |
Times cited : (8)
|
References (7)
|